Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
117.28
+1.53 (1.32%)
At close: Jan 22, 2026, 4:00 PM EST
117.28
0.00 (0.00%)
After-hours: Jan 22, 2026, 4:21 PM EST
Guardant Health Employees
As of December 31, 2024, Guardant Health had 2,021 total employees, including 1,999 full-time and 22 part-time employees. The number of employees increased by 242 or 13.60% compared to the previous year.
Employees
2,021
Change (1Y)
242
Growth (1Y)
13.60%
Revenue / Employee
$446,595
Profits / Employee
-$197,323
Market Cap
15.11B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 2,021 | 242 | 13.60% | 1,999 | 22 |
| Dec 31, 2023 | 1,779 | -14 | -0.78% | 1,768 | 11 |
| Dec 31, 2022 | 1,793 | 420 | 30.59% | 1,793 | 0 |
| Dec 31, 2021 | 1,373 | 509 | 58.91% | 1,373 | 0 |
| Dec 31, 2020 | 864 | 242 | 38.91% | 864 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 70,000 |
| Quest Diagnostics | 56,000 |
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 20,100 |
| Mettler-Toledo International | 17,300 |
| Revvity | 11,000 |
| Illumina | 10,370 |
| Waters | 7,600 |
GH News
- 3 hours ago - FDA Approves Guardant Health's Blood Test To Guide Treatment For Advanced Colorectal Cancer - Benzinga
- 8 hours ago - Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for BRAFTOVI® (encorafenib) Combination in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer - Business Wire
- 11 hours ago - Alger Mid Cap Focus Fund Q4 2025 Portfolio Update - Seeking Alpha
- 3 days ago - Guardant Health Announces Multi-Year Strategic Collaboration Agreement with Merck to Develop Companion Diagnostics and Commercialize New Cancer Therapies Using Guardant Infinity Smart Platform - Business Wire
- 4 days ago - Guardant Health: Shield Colorectal Cancer Screening To Sustain Growth - Seeking Alpha
- 9 days ago - Guardant Health, Inc. (GH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results - Business Wire
- 14 days ago - Guardant Health's Shield Blood Test for Colorectal Cancer Screening Now Available for U.S. Military Members and Families - Business Wire